Figure 2From: Effect and safety of dual anti-human epidermal growth factor receptor 2 therapy compared to monotherapy in patients with human epidermal growth factor receptor 2-positive breast cancer: a systematic review Meta-analysis of pathologic complete response between dual anti-HER2 therapy and monotherapy groups. Back to article page